Stocks · Health care · Pharmaceutical Preparations

Edgewise Therapeutics, Inc.

EWTX Clue Score35
United States Fiscal year ends December CIK 0001710072 Results filed 4 Nov 2026

What the insiders did No buying or selling

By person

11 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Peter A. Thompson
Director
—
—
—
443,792
$19.26M
—
Orbimed Advisors LLC entity
Director
—
—
—
443,792
$19.26M
—
R Michael Carruthers
Chief Financial Officer
—
—
—
86,162
$3.74M
+10.6%
Kevin Koch
President and CEO
—
—
—
52,488
$2.28M
+262.5%
Behrad Derakhshan
Chief Business Officer
—
—
—
31,826
$1.38M
+89.0%
Alan J Russell
Chief Scientific Officer
—
—
—
31,466
$1.37M
+84.8%
Jonathan C Fox
Director
—
—
—
25,141
$1.09M
+131.6%
Badreddin Edris
Director
—
—
—
19,820
$860.32K
0.0%
John R Moore
General Counsel
—
—
—
17,697
$768.16K
+444.2%
Joanne M. Donovan
CMO
—
—
—
8,625
$374.38K
−53.9%
Marc Semigran
Chief Development Officer
—
—
—
6,716
$291.52K
0.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.